Form 6-K Acasti Pharma Inc. For: May 27

Go back to Form 6-K Acasti Pharma Inc. For: May 27

Neptune Technologies (NEPT) Misses Q4 EPS by 8c

May 28, 2015 6:23 AM EDT

Neptune Technologies (NASDAQ: NEPT) reported Q4 EPS of ($0.12), $0.08 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $4.02 million versus the consensus estimate of $5.6 million.

For earnings history and earnings-related data on Neptune Technologies (NEPT) click here.

... More